Image For Activity Cover
Diabetes Risk Scores: From development to population-wide implementation | Recording
The International Diabetes Federation (IDF) has estimated that the number of adults with diabetes is expected to rise from 425 million in 2017 to 629 million by 2045. Type 2 diabetes mellitus does not cause specific symptoms for many years at onset, which explains why between 25%-50% of the cases of Type 2 diabetes mellitus remain undiagnosed at any time in the community. Plasma glucose either fasting or 2 hours after a 75g glucose load and HbA1c levels are recommended methods for Type 2 diabetes mellitus diagnosis in the general population. However, these are invasive, expensive, and time-consuming procedures and, hence, are not suitable for mass screening. It has been shown that the most cost-efficient method for Type 2 diabetes mellitus screening in the general population is the use of a non-invasive tool for risk stratification as the first step followed by a blood test for glycaemia. Thus, screening for impaired glucose regulation (IGR) should be targeted to individuals at high risk of Type 2 diabetes mellitus. This webinar provides a brief overview of the current experience in developing and implementing diabetes risk scores in different parts of the world.
Speakers and Moderators

Jaakko Tuomilehto, MD, PhD
Professor Emeritus of Public Health of University of Helsinki, Finland

Pablo Aschner, MD
Associate Professor of Endocrinology, Javeriana University School of Medicine

Nanditha Arun, MD
Director and Consultant Diabetologist of Dr. A. Ramachandran's Diabetes Hospitals

Elisabetta Patorno, MD, DrPH

Noël Barengo, MD, PhD, MPH

Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered
American Diabetes Association 2451 Crystal Drive, Suite 900, Arlington, VA 22202 1-800-DIABETES
Follow us on
Copyright All rights reserved.
Powered By